A Long-Term Efficacy and Safety Study of Ixekizumab (LY2439821) in Participants With Active Psoriatic Arthritis
Status: | Completed |
---|---|
Conditions: | Arthritis, Psoriasis |
Therapuetic Areas: | Dermatology / Plastic Surgery, Rheumatology |
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 11/8/2018 |
Start Date: | September 14, 2015 |
End Date: | October 30, 2018 |
A Phase 3, Multicenter Study With a 36-Week Open-Label Period Followed by a Randomized Double-Blind Withdrawal Period From Week 36 to Week 104 to Evaluate the Long-Term Efficacy and Safety of Ixekizumab (LY2439821) 80 mg Every 2 Weeks in Biologic Disease-Modifying Antirheumatic Drug-Naive Patients With Active Psoriatic Arthritis
The main purpose of this study is to evaluate the safety and long-term efficacy of ixekizumab
compared to placebo in participants with active psoriatic arthritis.
compared to placebo in participants with active psoriatic arthritis.
Inclusion Criteria:
- Presents with established diagnosis of active psoriatic arthritis (PsA) for at least 6
months, and currently meets Classification for Psoriatic Arthritis (CASPAR) criteria
- Active PsA defined as the presence of at least 3 tender and at least 3 swollen joints
- Presence of active psoriatic skin lesion or a history of plaque psoriasis (Ps)
- Men must agree to use a reliable method of birth control or remain abstinent during
the study
- Women must agree to use reliable birth control or remain abstinent during the study
and for at least 12 weeks after stopping treatment
- Have been treated with 1 or more conventional disease-modifying antirheumatic drugs
(cDMARDs)
Exclusion Criteria:
- Current or prior use of biologic agents for treatment of Ps or PsA
- Inadequate response to greater than or equal to 4 conventional disease-modifying
antirheumatic drugs (DMARDS)
- Current use of more than one cDMARDs
- Diagnosis of active inflammatory arthritic syndromes or spondyloarthropathies other
than PsA
- Have received treatment with interleukin (IL) -17 or IL12/23 targeted monoclonal
antibody (MAb) therapy
- Serious disorder or illness other than psoriatic arthritis
- Serious infection within the last 3 months
- Breastfeeding or nursing (lactating) women
We found this trial at
23
sites
Phoenix, Arizona 85032
Principal Investigator: Ralph Bennett
Phone: 480-321-8580
Click here to add this to my saved trials
1709 S Rock Rd
Wichita, Kansas 67207
Wichita, Kansas 67207
316-689-6629
Principal Investigator: Shadi Shahouri
Phone: 316-689-6635
Click here to add this to my saved trials
Brooklyn, New York 11201
Principal Investigator: David Goddard
Phone: 646-962-4650
Click here to add this to my saved trials
Cedar Rapids, Iowa 52401
Principal Investigator: Michael Brooks
Phone: 319-398-1546
Click here to add this to my saved trials
Cumberland, Maryland 21502
Principal Investigator: Steven Klein
Phone: 301-724-6331
Click here to add this to my saved trials
Cypress, Texas 77429
Principal Investigator: Asif Cochinwala
Phone: 713-333-9323
Click here to add this to my saved trials
Dallas, Texas 75321
Principal Investigator: Alan Brodsky
Phone: 214-696-1600
Click here to add this to my saved trials
Durham, North Carolina 27704
Principal Investigator: Irene Whitt
Phone: 919-220-5255
Click here to add this to my saved trials
Glendale, Arizona 85304
Principal Investigator: Ramina Jajoo
Phone: 480-626-6654
Click here to add this to my saved trials
Hagerstown, Maryland 21740
Principal Investigator: Mary Howell
Phone: 301-791-6680
Click here to add this to my saved trials
Kalispell, Montana 59901
Principal Investigator: Roger Diegel
Phone: 406-755-1460
Click here to add this to my saved trials
Kennewick, Washington 99336
Principal Investigator: Derek Peacock
Phone: 509-942-2528
Click here to add this to my saved trials
Mesa, Arizona 85202
Principal Investigator: Paul Caldron
Phone: 480-321-8580
Click here to add this to my saved trials
Orange Park, Florida 32073
Principal Investigator: Meera Oza
Phone: 904-276-0001
Click here to add this to my saved trials
Click here to add this to my saved trials
Sacramento, California 95817
Principal Investigator: Siba Raychaudhuri
Phone: 916-473-7000
Click here to add this to my saved trials
San Leandro, California 94578
Principal Investigator: C. Michael Neuwelt
Phone: 510-357-1303
Click here to add this to my saved trials
Seattle, Washington 98104
Principal Investigator: Philip Mease
Phone: 206-386-2000
Click here to add this to my saved trials
Spokane, Washington 99204
Principal Investigator: Eric Mueller
Phone: 509-838-6500
Click here to add this to my saved trials
Voorhees, New Jersey 08043
Principal Investigator: Sheldon Solomon
Phone: 856-424-5005
Click here to add this to my saved trials
Worcester, Massachusetts 01655
Principal Investigator: Jonathan Kay
Phone: 508-334-6273
Click here to add this to my saved trials
Wyomissing, Pennsylvania 19610
Principal Investigator: Gregory Emkey
Click here to add this to my saved trials
Zephyrhills, Florida 33542
Principal Investigator: David Sikes
Phone: 813-780-8368
Click here to add this to my saved trials